Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Isracann Biosciences Inc ISCNF

Cannabis
Isracann Biosciences Inc. is a Canada-based cannabis company. The principal business focus of the Company is medical cannabis cultivation and distribution to provide products to the Israeli medical cannabis market, and to develop and validate Natural Health Products (NHP), through the Company’s operating subsidiaries. The Company's segments include Head Office, Medical Cannabis and Natural... see more

Recent & Breaking News (GREY:ISCNF)

CSE Bulletin: Delist - Isracann Biosciences Inc. (IPOT)

Newsfile 11 days ago

CSE Bulletin: Suspensions (IPOT, TCAN)

Newsfile April 6, 2023

IIROC Trading Halt - IPOT

Canada NewsWire April 6, 2023

Allkem Limited (TSX:AKE) successfully produces first lithium hydroxide product

Sabrina Cuthbert November 15, 2022

Isracann Biosciences Provides Bi-Weekly Default Status Report

GlobeNewswire October 13, 2022

Isracann Biosciences Announces Delay in Filing Annual Financial Statements

GlobeNewswire September 29, 2022

Isracann Bioscience (CSE:IPOT) facilitated genetics arrive in Israel

John Ballem  September 28, 2022

Isracann Bioscience Facilitated Genetics Arrive in Israel

GlobeNewswire September 28, 2022

Isracann Biosciences (CSE:IPOT) completes first cannabis genetics shipment to Israel

John Ballem  September 14, 2022

Isracann Bioscience Facilitates Cannabis Genetics Shipment to Israel

GlobeNewswire September 14, 2022

Isracann Biosciences (CSE:IPOT) signs distribution agreement with Pure Integrative Pharmacy

Shoran Devi September 1, 2022

Praesidio signs distribution agreement with Pure Integrative Pharmacy

GlobeNewswire September 1, 2022

Isracann Biosciences (CSE:IPOT) adds Mark Rypien to its advisory board

John Ballem  August 23, 2022

Isracann Adds Super Bowl MVP and Mental Health Advocate Mark Rypien to Advisory Board

GlobeNewswire August 23, 2022

Isracann Biosciences (CSE:IPOT) closes first tranche of private placement

John Ballem  August 3, 2022

Isracann Biosciences Announces Closing of First Tranche of $0.05 Unit Private Placement

GlobeNewswire August 3, 2022

Isracann Biosciences Subsidiary Praesidio Health Submits NPNs to Health Canada

GlobeNewswire May 19, 2022

Isracann Biosciences (CSE:IPOT) renews leadership and announces private placement

Brieanna McCutcheon  April 18, 2022

Isracann Biosciences Renews Leadership to Meet Changing Demands

GlobeNewswire April 15, 2022

Isracann Biosciences (CSE:IPOT) acquires natural health medicine developer

Brieanna McCutcheon  April 13, 2022